The Online Resource for
the ESC & iPSC Research Community
#htmlcaption1
 
 

TWITTER FEED

SUBSCRIBE

Sign up today to save time and keep current by receiving free, weekly science newsletters delivered directly to your inbox!
  • “I really enjoy your newsletters and look forward to receiving them.”

    – Kathryn Futrega, B.Sc
    PhD Student
    Queensland University of Technology

  • “Thank you so much for your email and your great newsletters. My team and I really enjoy them, and I cover your “MSC news” in our group meeting each Monday.”

    – Jan Nolta, PhD
    Professor, UC Davis School of Medicine

  • “I often look forward to the weekly summaries from Connexon.”

    – Kristopher Lofgren, PhD
    Boston Children’s Hospital

  • “Great newsletter, especially like the weekly summary of articles in my field in my inbox so I don’t have to go looking for them.”

    – Jennifer Adair, PhD, Fred Hutchinson Cancer Research Center and University of Washington

  • “I inadvertently got signed up for the newsletter. But because I found it so useful and informative, I have remained subscribed and actually recommended it to others.”

    – Gregory Weber, PhD
    Rutgers, The State University of New Jersey

  • “I have found these newsletters to be very valuable resources.”

    – Dean Yamaguchi, MD, PhD
    Associate Chief of Staff
    VA Greater Los Angeles Healthcare System

 

About ESC & iPSC News

History:

ESC & iPSC News was the second addition to the Connexon Creative suite of science newsletters and remains one of our most popular publications. Published every week since it was launched in 2007, ESC & iPSC News continues to provide scientists focusing on embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) with free, one-stop access to the most up-to-date publications and research news.

Scope:

The ESC and iPSC field has seen enormous advancement and evolution since we first started producing ESC & iPSC News in 2007. As with all of our publications, our goal with ESC & iPSC News is to support and facilitate this advancement by keeping the embryonic and induced pluripotent stem cell research community current with their field. By consistently identifying and compiling the most recent, relevant research articles, focusing specifically on stem cell isolation and differentiation, regulation of pluripotency, reprogramming of somatic cells to generate iPSCs, and the advancement of clinical applications of ESCs and iPSCs in regenerative medicine and cancer treatments, we allow our readers to devote less time to searching through literature and more time on their research interests. In addition to highlighting cutting edge research articles, ESC & iPSC News features press releases from key academic research institutions as well as ESC and iPSC industry and policy updates relating to business and regulatory affairs. We also keep our readers informed of the latest career opportunities, upcoming conferences and events in ESC and iPSC research.

Audience:

ESC & iPSC News is sent to approximately 4,500 international subscribers weekly, making it one of our most established and highly valued publications. Our subscribers are comprised of academic and industry researchers, biotech and pharma professionals, and members of the medical community that share a common interest in ESC and iPSC research, policy and industry news. In addition to the weekly newsletter, we keep the stem cell field engaged and up to date with daily updates via our ESC & iPSC News Twitter feed @ESC_iPSC_News. Finally, in keeping with our commitment to the effective and timely communication of science to scientists, we welcome submissions of recently published ESC and iPSC research articles, reviews, press releases, jobs and events to our editorial board.

New: STEMdiff™ Definitive Endoderm Kit For Easy, Standardized hPSC Differentiation
 
RELATED PUBLICATIONS